✦ LIBER ✦

Antineutrophil cytoplasmic antibodies in polyarteritis nodosa related to hepatitis B virus

✍ Scribed by L. Guillevin; H. Visser; F. Oksman; J. Pourrat

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 195 KB
Volume: 33
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780331223

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short-term corticosteroids then lamivudi

Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa

✍ Guillevin, L. ;Mahr, A. ;Cohen, P. ;Larroche, C. ;Queyrel, V. ;Loustaud-Ratti, V 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

## Abstract ## Objective To assess the efficacy and safety of lamivudine, an antiviral agent that strongly inhibits hepatitis B virus (HBV) DNA replication, combined with plasma exchanges after short‐term corticosteroids for HBV‐related polyartertitis nodosa (PAN). ## Methods Ten patients (8 men

Clinical images: Non–hepatitis B virus–r

Clinical images: Non–hepatitis B virus–related polyarteritis nodosa presenting with fever and diffuse intra-abdominal microaneurysms

✍ Ko-Jen Li; Song-Chou Hsieh; Yun-Chen Toh; Chia-Li Yu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

Positive classic antineutrophil cytoplas

Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis

✍ Slot, Marjan C. ;Tervaert, Jan Willem Cohen ;Boomsma, Maarten M. ;Stegeman, Coen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Objective: To analyze disease-free survival in patients with antineutrophil cytoplasmic antibody (anca)-associated small-vessel vasculitis (aav) treated with cyclophosphamide only or switched to azathioprine after 3 months of full remission while taking cyclophosphamide. ## Methods: We analyze

Analysis of the Hepatitis B virus precor

Analysis of the Hepatitis B virus precore and ORF-X sequences in patients with antibody to hepatitis B e antigen with and without normal ALT levels

✍ Cabrerizo, María; Bartolomé, Javier; Iñigo, Elena R.; López-Alcorocho, Juan Manu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

Serum samples from 20 anti-hepatitis B e antigenpositive patients with and without normal alanine aminotransferase (ALT) levels who had serum hepatitis B virus (HBV) DNA detectable only by polymerase chain reation (PCR) were examined. Viral DNA was amplified by PCR, using primers that encompassed pr

Detection of mutations in the enhancer 2

Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: Comparison with mutations in precore and core regions in relation to clinical status

✍ Honda, Arata; Yokosuka, Osamu; Ehata, Toshiki; Tagawa, Masami; Imazeki, Fumio; S 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 2 views

To investigate the meaning of the mutations in the enhancer 2/core promoter (Enh2/CP) region of hepatitis B virus (HBV) during the chronic HBV infection, mutations were examined in the Enh2/ CP region (carboxyl half of X region) and their correlation with mutations in the precore and core regions in

Distinct prevalence of antibodies to the

Distinct prevalence of antibodies to the E2 protein of GB virus C/hepatitis G virus in different parts of the world

✍ Ross, R. S.; Viazov, S.; Schmitt, U.; Schmolke, S.; Tacke, M.; Ofenloch-Haehnle, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 2 views